| Year |
Citation |
Score |
| 2019 |
Ando Y, Siegler EL, Ta HP, Cinay GE, Zhou H, Gorrell KA, Au H, Jarvis BM, Wang P, Shen K. Evaluating CAR-T Cell Therapy in a Hypoxic 3D Tumor Model. Advanced Healthcare Materials. e1900001. PMID 30734529 DOI: 10.1002/Adhm.201900001 |
0.324 |
|
| 2019 |
Qu Y, Siegler E, Cheng C, Liu J, Cinay G, Bagrodia N, Wang P. Engineering CAR-expressing natural killer cells with cytokine signaling and synthetic switch for an off-the-shelf cell-based cancer immunotherapy Mrs Communications. 9: 433-440. DOI: 10.1557/Mrc.2019.31 |
0.338 |
|
| 2018 |
Siriwon N, Kim YJ, Siegler EL, Chen X, Rohrs JA, Liu Y, Wang P. CAR-T Cells Surface-Engineered with Drug-Encapsulated Nanoparticles Can Ameliorate Intratumoral T Cell Hypofunction. Cancer Immunology Research. PMID 29720380 DOI: 10.1158/2326-6066.Cir-17-0502 |
0.344 |
|
| 2018 |
Liu Y, Zhu B, Jia Q, He F, Fang H, Chen J, Shi Z, Jin T, Wei B, Xie R, Li Q, Wang P. Durable clinical responses observed from non-Hodgkin lymphoma patients treated with autologous CAR-T cells targeting CD19. Journal of Clinical Oncology. 36: 3045-3045. DOI: 10.1200/Jco.2018.36.15_Suppl.3045 |
0.317 |
|
| 2018 |
Liu Y, Chen Z, Fang H, Wei R, Yu K, Jiang S, Fu W, Jiang H, Du J, He F, Xie R, Chen J, Wei B, Tao J, Wang P. Durable Remission Achieved from Bcma-Directed CAR-T Therapy Against Relapsed or Refractory Multiple Myeloma Blood. 132: 956-956. DOI: 10.1182/Blood-2018-99-112786 |
0.309 |
|
| 2018 |
Siegler EL, Wang P. Abstract A59: Expression of membrane-bound IL-15/IL-15Rα complex in chimeric antigen receptor-engineered natural killer cells for enhanced efficacy against solid tumors Cancer Immunology Research. 6. DOI: 10.1158/2326-6074.Tumimm17-A59 |
0.308 |
|
| 2018 |
Rohrs JA, Zheng D, Graham NA, Wang P, Finley SD. Abstract A53: Mechanistic model predicts effects of altering CD3ζ immuno-tyrosine activating motif (ITAM) structure in chimeric antigen receptor- (CAR-) engineered T cells Cancer Immunology Research. 6. DOI: 10.1158/2326-6074.Tumimm17-A53 |
0.324 |
|
| 2018 |
Rohrs JA, Zheng D, Graham NA, Wang P, Finley SD. Abstract NG01: Effects of altering receptor structure in CAR T cells: Predictions from an experimentally-validated systems biology model Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-Ng01 |
0.328 |
|
| 2017 |
Siegler EL, Kim YJ, Chen X, Siriwon N, Mac J, Rohrs JA, Bryson PD, Wang P. Combination Cancer Therapy Using Chimeric Antigen Receptor-Engineered Natural Killer Cells as Drug Carriers. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 28919377 DOI: 10.1016/J.Ymthe.2017.08.010 |
0.354 |
|
| 2017 |
Bryson PD, Han X, Truong N, Wang P. Breast cancer vaccines delivered by dendritic cell-targeted lentivectors induce potent antitumor immune responses and protect mice from mammary tumor growth. Vaccine. PMID 28916248 DOI: 10.1016/J.Vaccine.2017.09.017 |
0.309 |
|
| 2017 |
Wang P, Li S, Siriwon N, Zhang X, Yang S, Jin T, He F, Kim YJ, Mac J, Lu Z, Wang S, Han X. Enhanced Cancer Immunotherapy by Chimeric Antigen Receptor-Modified T Cells Engineered to Secrete Checkpoint Inhibitors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28912137 DOI: 10.1158/1078-0432.Ccr-17-0867 |
0.322 |
|
| 2017 |
Siegler E, Li S, Kim YJ, Wang P. Designed Ankyrin Repeat Proteins as Her2 Targeting Domains in Chimeric Antigen Receptor-Engineered T Cells. Human Gene Therapy. PMID 28796529 DOI: 10.1089/Hum.2017.021 |
0.364 |
|
| 2017 |
Han X, Cinay GE, Zhao Y, Guo Y, Zhang X, Wang P. Adnectin-Based Design of Chimeric Antigen Receptor for T Cell Engineering. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 28784559 DOI: 10.1016/J.Ymthe.2017.07.009 |
0.363 |
|
| 2017 |
Kim JT, Liu Y, Kulkarni RP, Lee KK, Dai B, Lovely G, Ouyang Y, Wang P, Yang L, Baltimore D. Dendritic cell-targeted lentiviral vector immunization uses pseudotransduction and DNA-mediated STING and cGAS activation. Science Immunology. 2. PMID 28733470 DOI: 10.1126/Sciimmunol.Aal1329 |
0.346 |
|
| 2017 |
Han X, Bryson PD, Zhao Y, Cinay GE, Li S, Guo Y, Siriwon N, Wang P. Masked Chimeric Antigen Receptor for Tumor-Specific Activation. Molecular Therapy : the Journal of the American Society of Gene Therapy. 25: 274-284. PMID 28129121 DOI: 10.1016/J.Ymthe.2016.10.011 |
0.361 |
|
| 2016 |
Rohrs JA, Wang P, Finley SD. Predictive Model of Lymphocyte-Specific Protein Tyrosine Kinase (LCK) Autoregulation. Cellular and Molecular Bioengineering. 9: 351-367. PMID 27547268 DOI: 10.1007/S12195-016-0438-7 |
0.302 |
|
| 2016 |
Fang J, Hu B, Li S, Zhang C, Liu Y, Wang P. A multi-antigen vaccine in combination with an immunotoxin targeting tumor-associated fibroblast for treating murine melanoma. Molecular Therapy Oncolytics. 3: 16007. PMID 27119119 DOI: 10.1038/Mto.2016.7 |
0.353 |
|
| 2016 |
Siegler EL, Kim YJ, Wang P. Nanomedicine targeting the tumor microenvironment: Therapeutic strategies to inhibit angiogenesis, remodel matrix, and modulate immune responses Journal of Cellular Immunotherapy. 2: 69-78. DOI: 10.1016/J.Jocit.2016.08.002 |
0.314 |
|
| 2015 |
Wang H, Wang P, Li L, Zhang K, Wang X, Liu Q. Microbubbles Enhance the Antitumor Effects of Sinoporphyrin Sodium Mediated Sonodynamic Therapy both In Vitro and In Vivo. International Journal of Biological Sciences. 11: 1401-9. PMID 26681919 DOI: 10.7150/ijbs.12802 |
0.439 |
|
| 2015 |
Ablikim M, Achasov MN, Ai XC, Albayrak O, Albrecht M, Ambrose DJ, Amoroso A, An FF, An Q, Bai JZ, Ferroli RB, Ban Y, Bennett DW, Bennett JV, Bertani M, ... Wang P, ... Wang PL, et al. Observation of a Neutral Structure near the DD[over ¯]^{*} Mass Threshold in e^{+}e^{-}→(DD[over ¯]^{*})^{0}π^{0} at sqrt[s]=4.226 and 4.257 GeV. Physical Review Letters. 115: 222002. PMID 26650295 DOI: 10.1103/Physrevlett.115.222002 |
0.371 |
|
| 2015 |
Ablikim M, Achasov MN, Ai XC, Albayrak O, Albrecht M, Ambrose DJ, Amoroso A, An FF, An Q, Bai JZ, Baldini Ferroli R, Ban Y, Bennett DW, Bennett JV, Bertani M, ... Wang P, ... Wang PL, et al. Measurement of the Absolute Branching Fraction for Λ_{c}^{+}→Λe^{+}ν_{e}. Physical Review Letters. 115: 221805. PMID 26650293 DOI: 10.1103/Physrevlett.115.221805 |
0.38 |
|
| 2015 |
Ablikim M, Achasov MN, Ai XC, Albayrak O, Albrecht M, Ambrose DJ, Amoroso A, An FF, An Q, Bai JZ, Ferroli RB, Ban Y, Bennett DW, Bennett JV, Bertani M, ... Wang P, ... Wang PL, et al. Observation of a Neutral Charmoniumlike State Z_{c}(4025)^{0} in e^{+}e^{-}→(D^{*}D[over ¯]^{*})^{0}π^{0}. Physical Review Letters. 115: 182002. PMID 26565461 DOI: 10.1103/Physrevlett.115.182002 |
0.373 |
|
| 2015 |
Fang J, Xiao L, Joo KI, Liu Y, Zhang C, Liu S, Conti PS, Li Z, Wang P. A Potent Immunotoxin Targeting Fibroblast Activation Protein for Treatment of Breast Cancer in Mice. International Journal of Cancer. Journal International Du Cancer. PMID 26334777 DOI: 10.1002/Ijc.29831 |
0.341 |
|
| 2015 |
Kim YJ, Liu Y, Li S, Rohrs J, Zhang R, Zhang X, Wang P. Co-Eradication of Breast Cancer Cells and Cancer Stem Cells by Cross-Linked Multilamellar Liposomes Enhances Tumor Treatment. Molecular Pharmaceutics. PMID 26098197 DOI: 10.1021/Mp500754R |
0.303 |
|
| 2015 |
Liu Y, Siriwon N, Rohrs JA, Wang P. Generation of Targeted Adeno-Associated Virus (AAV) Vectors for Human Gene Therapy. Current Pharmaceutical Design. 21: 3248-56. PMID 26027561 DOI: 10.2174/1381612821666150531171653 |
0.321 |
|
| 2014 |
Liu Y, Kim YJ, Ji M, Fang J, Siriwon N, Zhang LI, Wang P. Enhancing gene delivery of adeno-associated viruses by cell-permeable peptides. Molecular Therapy. Methods & Clinical Development. 1: 12. PMID 26015948 DOI: 10.1038/Mtm.2013.12 |
0.32 |
|
| 2014 |
Zhang C, Hu B, Xiao L, Liu Y, Wang P. Pseudotyping lentiviral vectors with lymphocytic choriomeningitis virus glycoproteins for transduction of dendritic cells and in vivo immunization. Human Gene Therapy Methods. 25: 328-38. PMID 25416034 DOI: 10.1089/Hgtb.2014.105 |
0.365 |
|
| 2014 |
Liu Y, Fang J, Joo KI, Wong MK, Wang P. Codelivery of chemotherapeutics via crosslinked multilamellar liposomal vesicles to overcome multidrug resistance in tumor. Plos One. 9: e110611. PMID 25330237 DOI: 10.1371/Journal.Pone.0110611 |
0.305 |
|
| 2014 |
Zhao M, Liu Y, Hsieh RS, Wang N, Tai W, Joo KI, Wang P, Gu Z, Tang Y. Clickable protein nanocapsules for targeted delivery of recombinant p53 protein. Journal of the American Chemical Society. 136: 15319-25. PMID 25289975 DOI: 10.1021/Ja508083G |
0.477 |
|
| 2014 |
Liu Y, Joo KI, Lei Y, Wang P. Visualization of intracellular pathways of engineered baculovirus in mammalian cells. Virus Research. 181: 81-91. PMID 24457070 DOI: 10.1016/J.Virusres.2014.01.006 |
0.326 |
|
| 2014 |
Bryson PD, Han X, Truong N, Wang P. Abstract 2888: Dendritic cell-targeted lentiviral vector vaccines overcome tolerance to generate a protective T-cell immune response to breast cancer antigens ERBB2 and α-lactalbumin Cancer Research. 74: 2888-2888. DOI: 10.1158/1538-7445.Am2014-2888 |
0.324 |
|
| 2013 |
Bryson PD, Zhang C, Lee CL, Wang P. A tetracycline-regulated cell line produces high-titer lentiviral vectors that specifically target dendritic cells. Journal of Visualized Experiments : Jove. PMID 23851977 DOI: 10.3791/50606 |
0.358 |
|
| 2013 |
Liu Y, Tai A, Joo KI, Wang P. Visualization of DC-SIGN-mediated entry pathway of engineered lentiviral vectors in target cells. Plos One. 8: e67400. PMID 23840690 DOI: 10.1371/Journal.Pone.0067400 |
0.348 |
|
| 2013 |
Liu Y, Ji M, Wong MK, Joo KI, Wang P. Enhanced therapeutic efficacy of iRGD-conjugated crosslinked multilayer liposomes for drug delivery. Biomed Research International. 2013: 378380. PMID 23691500 DOI: 10.1155/2013/378380 |
0.315 |
|
| 2013 |
Xiao L, Hung KC, Takahashi TT, Joo KI, Lim M, Roberts RW, Wang P. Antibody-mimetic ligand selected by mRNA display targets DC-SIGN for dendritic cell-directed antigen delivery. Acs Chemical Biology. 8: 967-77. PMID 23427768 DOI: 10.1021/Cb300680C |
0.314 |
|
| 2013 |
Chooi YH, Fang J, Liu H, Filler SG, Wang P, Tang Y. Genome mining of a prenylated and immunosuppressive polyketide from pathogenic fungi. Organic Letters. 15: 780-3. PMID 23368997 DOI: 10.1021/Ol303435Y |
0.38 |
|
| 2013 |
Liu Y, Fang Y, Zhou Y, Zandi E, Lee CL, Joo KI, Wang P. Site-specific modification of adeno-associated viruses via a genetically engineered aldehyde tag. Small (Weinheim An Der Bergstrasse, Germany). 9: 421-9. PMID 23038676 DOI: 10.1002/Smll.201201661 |
0.339 |
|
| 2013 |
Zhao M, Hu B, Gu Z, Joo K, Wang P, Tang Y. Degradable polymeric nanocapsule for efficient intracellular delivery of a high molecular weight tumor-selective protein complex Nano Today. 8: 11-20. DOI: 10.1016/J.Nantod.2012.12.003 |
0.363 |
|
| 2012 |
Xiao L, Joo KI, Lim M, Wang P. Dendritic cell-directed vaccination with a lentivector encoding PSCA for prostate cancer in mice. Plos One. 7: e48866. PMID 23139820 DOI: 10.1371/Journal.Pone.0048866 |
0.309 |
|
| 2012 |
Chooi YH, Wang P, Fang J, Li Y, Wu K, Wang P, Tang Y. Discovery and characterization of a group of fungal polycyclic polyketide prenyltransferases. Journal of the American Chemical Society. 134: 9428-37. PMID 22590971 DOI: 10.1021/Ja3028636 |
0.401 |
|
| 2012 |
Xiao L, Kim J, Lim M, Dai B, Yang L, Reed SG, Baltimore D, Wang P. A TLR4 agonist synergizes with dendritic cell-directed lentiviral vectors for inducing antigen-specific immune responses. Vaccine. 30: 2570-81. PMID 22314134 DOI: 10.1016/J.Vaccine.2012.01.074 |
0.309 |
|
| 2012 |
Lee CL, Chou M, Dai B, Xiao L, Wang P. Construction of stable producer cells to make high-titer lentiviral vectors for dendritic cell-based vaccination. Biotechnology and Bioengineering. 109: 1551-60. PMID 22179950 DOI: 10.1002/Bit.24413 |
0.347 |
|
| 2011 |
Lee CL, Dang J, Joo KI, Wang P. Engineered lentiviral vectors pseudotyped with a CD4 receptor and a fusogenic protein can target cells expressing HIV-1 envelope proteins. Virus Research. 160: 340-50. PMID 21802459 DOI: 10.1016/J.Virusres.2011.07.010 |
0.317 |
|
| 2011 |
Zhao M, Biswas A, Hu B, Joo KI, Wang P, Gu Z, Tang Y. Redox-responsive nanocapsules for intracellular protein delivery. Biomaterials. 32: 5223-30. PMID 21514660 DOI: 10.1016/J.Biomaterials.2011.03.060 |
0.474 |
|
| 2011 |
Joo KI, Fang Y, Liu Y, Xiao L, Gu Z, Tai A, Lee CL, Tang Y, Wang P. Enhanced real-time monitoring of adeno-associated virus trafficking by virus-quantum dot conjugates. Acs Nano. 5: 3523-35. PMID 21473596 DOI: 10.1021/Nn102651P |
0.404 |
|
| 2011 |
Froelich S, Tai A, Kennedy K, Zubair A, Wang P. Pseudotyping lentiviral vectors with aura virus envelope glycoproteins for DC-SIGN-mediated transduction of dendritic cells. Human Gene Therapy. 22: 1281-91. PMID 21452926 DOI: 10.1089/Hum.2010.196 |
0.301 |
|
| 2011 |
Yang HG, Hu BL, Xiao L, Wang P. Dendritic cell-directed lentivector vaccine induces antigen-specific immune responses against murine melanoma Cancer Gene Therapy. 18: 370-380. PMID 21372855 DOI: 10.1038/Cgt.2011.13 |
0.34 |
|
| 2011 |
Lei Y, Lee CL, Joo KI, Zarzar J, Liu Y, Dai B, Fox V, Wang P. Gene editing of human embryonic stem cells via an engineered baculoviral vector carrying zinc-finger nucleases. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 942-50. PMID 21326219 DOI: 10.1038/Mt.2011.12 |
0.332 |
|
| 2011 |
Tai A, Froelich S, Joo KI, Wang P. Production of lentiviral vectors with enhanced efficiency to target dendritic cells by attenuating mannosidase activity of mammalian cells. Journal of Biological Engineering. 5: 1. PMID 21276219 DOI: 10.1186/1754-1611-5-1 |
0.343 |
|
| 2011 |
Biswas A, Joo KI, Liu J, Zhao M, Fan G, Wang P, Gu Z, Tang Y. Endoprotease-mediated intracellular protein delivery using nanocapsules. Acs Nano. 5: 1385-94. PMID 21268592 DOI: 10.1021/Nn1031005 |
0.458 |
|
| 2011 |
Hu B, Tai A, Wang P. Immunization delivered by lentiviral vectors for cancer and infectious diseases. Immunological Reviews. 239: 45-61. PMID 21198664 DOI: 10.1111/J.1600-065X.2010.00967.X |
0.329 |
|
| 2011 |
Zhao M, Hu B, Wang P, Tang Y. Abstract A115: Delivery of tumor-killing protein to cancer cells. Molecular Cancer Therapeutics. 10. DOI: 10.1158/1535-7163.Targ-11-A115 |
0.38 |
|
| 2010 |
Hu B, Dai B, Wang P. Vaccines delivered by integration-deficient lentiviral vectors targeting dendritic cells induces strong antigen-specific immunity. Vaccine. 28: 6675-83. PMID 20709004 DOI: 10.1016/J.Vaccine.2010.08.012 |
0.339 |
|
| 2010 |
Gu Z, Biswas A, Joo KI, Hu B, Wang P, Tang Y. Probing protease activity by single-fluorescent-protein nanocapsules. Chemical Communications (Cambridge, England). 46: 6467-9. PMID 20657917 DOI: 10.1039/C0Cc01439G |
0.403 |
|
| 2010 |
Joo KI, Tai A, Lee CL, Wong C, Wang P. Imaging multiple intermediates of single-virus membrane fusion mediated by distinct fusion proteins. Microscopy Research and Technique. 73: 886-900. PMID 20232362 DOI: 10.1002/Jemt.20841 |
0.31 |
|
| 2010 |
Froelich S, Tai A, Wang P. Lentiviral vectors for immune cells targeting. Immunopharmacology and Immunotoxicology. 32: 208-18. PMID 20085508 DOI: 10.3109/08923970903420582 |
0.342 |
|
| 2009 |
Gu Z, Yan M, Hu B, Joo KI, Biswas A, Huang Y, Lu Y, Wang P, Tang Y. Protein nanocapsule weaved with enzymatically degradable polymeric network. Nano Letters. 9: 4533-8. PMID 19995089 DOI: 10.1021/Nl902935B |
0.441 |
|
| 2009 |
Dai B, Yang L, Yang H, Hu B, Baltimore D, Wang P. HIV-1 Gag-specific immunity induced by a lentivector-based vaccine directed to dendritic cells. Proceedings of the National Academy of Sciences of the United States of America. 106: 20382-7. PMID 19918062 DOI: 10.1073/Pnas.0911742106 |
0.321 |
|
| 2009 |
Tang Y, Wang P, Van Deventer JA, Link AJ, Tirrell DA. Introduction of an aliphatic ketone into recombinant proteins in a bacterial strain that overexpresses an editing-impaired leucyl-tRNA synthetase. Chembiochem : a European Journal of Chemical Biology. 10: 2188-90. PMID 19670197 DOI: 10.1002/Cbic.200900407 |
0.719 |
|
| 2009 |
Hu B, Yang H, Dai B, Tai A, Wang P. Nonintegrating lentiviral vectors can effectively deliver ovalbumin antigen for induction of antitumor immunity. Human Gene Therapy. 20: 1652-1664. PMID 19663564 DOI: 10.1089/Hum.2009.012 |
0.34 |
|
| 2009 |
Lei Y, Joo K, Wang P. Engineering fusogenic molecules to achieve targeted transduction of enveloped lentiviral vectors Journal of Biological Engineering. 3: 8-8. PMID 19490632 DOI: 10.1186/1754-1611-3-8 |
0.322 |
|
| 2009 |
Froelich S, Ziegler L, Stroup K, Wang P. Targeted gene delivery to CD117-expressing cells in vivo with lentiviral vectors co-displaying stem cell factor and a fusogenic molecule Biotechnology and Bioengineering. 104: 206-215. PMID 19452500 DOI: 10.1002/Bit.22378 |
0.352 |
|
| 2009 |
Yang H, Joo K, Ziegler L, Wang P. Cell Type-Specific Targeting with Surface-Engineered Lentiviral Vectors Co-displaying OKT3 Antibody and Fusogenic Molecule Pharmaceutical Research. 26: 1432-1445. PMID 19259792 DOI: 10.1007/S11095-009-9853-Y |
0.33 |
|
| 2008 |
Ziegler L, Yang L, Joo Ki, Yang H, Baltimore D, Wang P. Targeting lentiviral vectors to antigen-specific immunoglobulins. Human Gene Therapy. 19: 861-72. PMID 18590376 DOI: 10.1089/Hum.2007.149 |
0.363 |
|
| 2008 |
Joo KI, Wang P. Visualization of targeted transduction by engineered lentiviral vectors Gene Therapy. 15: 1384-1396. PMID 18480844 DOI: 10.1038/Gt.2008.87 |
0.341 |
|
| 2008 |
Yang H, Ziegler L, Joo K, Cho T, Lei Y, Wang P. Gamma-retroviral vectors enveloped with an antibody and an engineered fusogenic protein achieved antigen-specific targeting. Biotechnology and Bioengineering. 101: 357-368. PMID 18435481 DOI: 10.1002/Bit.21903 |
0.356 |
|
| 2008 |
Yang L, Yang H, Rideout K, Cho T, Joo KI, Ziegler L, Elliot A, Walls A, Yu D, Baltimore D, Wang P. Engineered lentivector targeting of dendritic cells for in vivo immunization. Nature Biotechnology. 26: 326-34. PMID 18297056 DOI: 10.1038/Nbt1390 |
0.381 |
|
| 2006 |
Kwon I, Wang P, Tirrell DA. Design of a bacterial host for site-specific incorporation of p-bromophenylalanine into recombinant proteins. Journal of the American Chemical Society. 128: 11778-83. PMID 16953616 DOI: 10.1021/Ja0626281 |
0.649 |
|
| 2006 |
Yang L, Bailey L, Baltimore D, Wang P. Targeting lentiviral vectors to specific cell types in vivo. Proceedings of the National Academy of Sciences of the United States of America. 103: 11479-84. PMID 16864770 DOI: 10.1073/Pnas.0604993103 |
0.358 |
|
| 2004 |
Wang P, Fichera A, Kumar K, Tirrell DA. Alternative translations of a single RNA message: an identity switch of (2S,3R)-4,4,4-trifluorovaline between valine and isoleucine codons. Angewandte Chemie (International Ed. in English). 43: 3664-6. PMID 15248267 DOI: 10.1002/Anie.200454036 |
0.457 |
|
| 2003 |
Wang P, Tang Y, Tirrell DA. Incorporation of trifluoroisoleucine into proteins in vivo. Journal of the American Chemical Society. 125: 6900-6. PMID 12783542 DOI: 10.1021/Ja0298287 |
0.587 |
|
| 2002 |
Wang P, Vaidehi N, Tirrell DA, Goddard WA. Virtual screening for binding of phenylalanine analogues to phenylalanyl-tRNA synthetase. Journal of the American Chemical Society. 124: 14442-9. PMID 12452720 DOI: 10.1021/Ja0175441 |
0.481 |
|
| 2002 |
Datta D, Wang P, Carrico IS, Mayo SL, Tirrell DA. A designed phenylalanyl-tRNA synthetase variant allows efficient in vivo incorporation of aryl ketone functionality into proteins. Journal of the American Chemical Society. 124: 5652-3. PMID 12010034 DOI: 10.1021/Ja0177096 |
0.518 |
|
| Show low-probability matches. |